Working in silos, change will not occur. WBC convenes with our Partners, Champions, and Sponsors to move faster together toward our action initiative goals.
Join us for Our Annual Action for Impact Summit!
WBC’s Annual Action for Impact Summit unites thousands of attendees on a fully interactive platform, enabling participants to network, connect, and exchange ideas, innovations, and impact in real time.
WOMEN CEO REPORT
Lara S. Sullivan, M.D., is the CEO of Pyxis Oncology, Inc., a biopharmaceutical company focused on developing innovative therapies for oncology. Dr. Sullivans leadership is defined by her dedication to advancing cancer research, driving clinical development, and addressing unmet medical needs in oncology. With extensive experience in oncology and drug development, she has been instrumental in guiding Pyxis Oncology through key stages of research and clinical trials. Her strategic vision and commitment to improving patient outcomes continue to drive the companys success. Under her guidance, Pyxis Oncology is advancing its mission to develop cutting-edge therapies and contribute to the evolving landscape of cancer treatment.
